South African pharmaceutical company Aspen Pharmacare said on Monday it had entered into a preliminary agreement with Johnson & Johnson to commercially manufacture its COVID-19 vaccine candidate.
Aspen said it had agreed to provide capacity required for the manufacture of J&J’s vaccine candidate, which is still undergoing clinical trials, at its Port Elizabeth facility.
Aspen will perform formulation, filling and secondary packaging of the vaccine for supply to Johnson & Johnson, the company said.
Follow us on:
Former US President Donald Trump on Saturday declined a second debate with Vice President Kamala…
Munich's Mayor Dieter Reiter has officially opened Oktoberfest at noon Saturday by tapping the first…
Daniel Dubois scored an upset victory and ruined Anthony Joshua's return to London's Wembley Stadium…
Elon Musk’s social media platform, X, has named Rachel de Oliveira Conceicao as its legal…
In a surprising turn during the Edo state governorship election, Olumide Akpata, the Labour Party…
The Governor of Ondo state, Mr. Lucky Aiyedatiwa, has vowed to transform the state into…